S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion

Abstract

These data suggest that S100P plays a major role in the aggressiveness of pancreatic cancer that is likely mediated by its ability to activate RAGE. Thus, interference with S100P may provide a novel approach for treatment of pancreatic cancer.